Koninklijke Dsm Nv Stock Price To Sales

KDSKFDelisted Stock  USD 25.30  0.00  0.00%   
Koninklijke DSM NV fundamentals help investors to digest information that contributes to Koninklijke DSM's financial success or failures. It also enables traders to predict the movement of Koninklijke Pink Sheet. The fundamental analysis module provides a way to measure Koninklijke DSM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Koninklijke DSM pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Koninklijke DSM NV Company Price To Sales Analysis

Koninklijke DSM's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Koninklijke DSM Price To Sales

    
  2.27 X  
Most of Koninklijke DSM's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke DSM NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, Koninklijke DSM NV has a Price To Sales of 2.2674 times. This is 91.45% lower than that of the Basic Materials sector and 99.37% lower than that of the Specialty Chemicals industry. The price to sales for all United States stocks is 80.15% higher than that of the company.

Koninklijke Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Koninklijke DSM's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Koninklijke DSM could also be used in its relative valuation, which is a method of valuing Koninklijke DSM by comparing valuation metrics of similar companies.
Koninklijke DSM is currently under evaluation in price to sales category among its peers.

Koninklijke Fundamentals

About Koninklijke DSM Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Koninklijke DSM NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Koninklijke DSM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Koninklijke DSM NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Koninklijke Pink Sheet

If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Correlations
Find global opportunities by holding instruments from different markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity